SOURCE: Cypress Bioscience, Inc.

November 26, 2007 06:30 ET

Cypress Bioscience, Inc. to Present at Lazard Capital Markets Fourth Annual Healthcare Conference

SAN DIEGO, CA--(Marketwire - November 26, 2007) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at Lazard Capital Markets Fourth Annual Healthcare conference on Tuesday, November 27, 2007.

The Lazard conference is being held at the New York Palace Hotel, New York, NY. Ms. Johnson is scheduled to present on Tuesday, November 27th at 8:00 a.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience, Inc.

Cypress is committed to being an innovator and leader in providing products for the treatment of patients with Fibromyalgia Syndrome (FMS). We continue to evaluate various other potential strategic transactions, including the potential acquisition of products, product candidates, technologies and companies.

For more information about Cypress, please visit the Company's web site at

Contact Information

  • For additional information please contact
    For Cypress Bioscience:
    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer and Chief Financial Officer

    Mary Gieson
    Investor Relations
    (858) 452-2323